News and Press Releases
Grifols Procleix ArboPlex Assay Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
Grifols’ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitted infections Arboviruses are a growing emerging threat, with changes in climate and increasing...
Category: Biotechnology, Pharmaceutical
Posted: April 4, 2024
Avinguda de la Generalitat, 152 Parc empresarial Can Sant Joan 08174 Sant Cugat del Vallès, Barcelona SPAIN
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study
The UK’s Medical Research Council is funding a 10-patient phase 1 study to deliver rapid personalised treatment for lung cancer patients 3 April 2024 -- Hampton, UK -- Touchlight, a...
Category: Biotechnology, Clinical Trials
Posted: April 3, 2024
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research
Paper on the ground-breaking research by Genzeva, LumaGene, RYLTI, Brigham & Women’s Hospital of Harvard University, and QIAGEN Digital Insights was published this week in the Journal of Molecular Diagnostics 3 April...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: April 3, 2024
dsm-firmenich and OMG Pharma form strategic collaboration to advance first-of-a-kind CBD-based drugs for insomnia
3 April 2024 – Kaiseraugst, Switzerland; Heerlen, Netherlands – dsm-firmenich, has announced a new strategic collaboration with Oz Medicann Group (OMG) Pharma – an Australian-based biotech innovator in the cannabinoid...
Category: Biotechnology, Drug Delivery
Posted: April 3, 2024
Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials
Headlands Research Orlando satisfies the organisations’ commitment to create multiple research sites aimed at increasing health equity in clinical research 28 March 2024 -- California, US -- Headlands Research, a...
Category: Clinical Trials
Posted: April 2, 2024
Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
Highly Sensitive and Multiplexed Assay for the Detection, Discrimination and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600 Droplet Digital PCR System 2 April...
Category: Clinical Trials
Posted: April 2, 2024
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET
Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed
CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials 2 April 2024 -- Pennsylvania, US -- A comprehensive...
Category: Other, Pharmaceutical
Posted: April 2, 2024
X‑Chem Adds Chief Technology Officer to Bolster Its Digital Drug Discovery Strategy
2 April 2024 -- Massachusetts, US -- X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the addition of Dr Erin Davis as chief technology officer....
Category: Drug Discovery
Posted: April 2, 2024
Nonacus launches test for comprehensive genomic profiling, integrated with bioinformatics and analysis software
2 April 2024 -- Birmingham, UK -- Genetic testing company, Nonacus, has launched GALEAS Tumor, a next generation sequencing (NGS) test that provides comprehensive genomic profiling of tumours, allowing clinicians...
Category: Biotechnology
Posted: April 2, 2024
Unit 5, Quinton Business Park, 11 Ridgeway, Quinton, Birmingham B32 1AF, United Kingdom
Bora Pharmaceuticals completes the acquisition of Upsher-Smith
Acquisition expands Bora’s North American footprint with first US manufacturing site 1 April 2024 -- Taipei, Taiwan -- Bora Pharmaceuticals today announced that it has completed the acquisition of Upsher-Smith Laboratories,...
Category: BioManufacturing
Posted: April 1, 2024
6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd., Neihu District, Taipei City, 114 Taiwan
Touchlight Awarded Tender to Supply Enzymatic dbDNA to CPI’s RNA Centre of Excellence
28 March 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO enabling the development of genetic medicines with its doggybone DNA (dbDNA) technology and leaders in enzymatic DNA production, is...
Category: Biotechnology
Posted: March 28, 2024
Aragen operationalises first phase of its Biologics manufacturing facility in India
Executes the first project for developing and manufacturing a novel anticancer mAb 28 March 2024 – Hyderabad, India – Aragen, a leading Contract Research Development and Manufacturing Organisation (CRDMO) for...
Category: Biotechnology, Drug Discovery
Posted: March 28, 2024
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
Highlights include environmental goals based on climate science, workforce empowerment, focus on local partnerships and supply chain resiliency 27 March 2024 -- Pennsylvania, US -- PCI Pharma Services, a leading...
Category: Drug Discovery, Manufacturing and Packing
Posted: March 27, 2024
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
27 March 2024 -- Princeton, US, and Frankfurt, Germany -- Indegene, a digital-first, life sciences commercialisation company, announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global provider...
Category: Pharmaceutical
Posted: March 27, 2024
Bio-Rad launches validated antibodies for Rare Cell and Circulating Tumour Cell Enumeration
Antibodies Validated for Use with Bio-Rad’s Celselect Slides Enumeration Stain Kits to Enable Immunostaining of Captured Circulating Tumor Cells in Liquid Biopsy Samples 26 March 2024 – Hercules, CA, US...
Category: Biotechnology, Drug Discovery
Posted: March 26, 2024
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET
